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Summary. The effects of long-term prostaglandin E 2 (PGE 2)
on cancellous bone in proximal tibial metaphysis were stud-
ied in 7-month-old male Sprague-Dawley rats given daily
subcutaneous injections of 0, l, 3, and 6 mg PGEE/kg/day
and sacrificed after 60, 120, and 180 days. Histomorphomet-
ric analyses were performed on double fluorescent-labeled
undecalcified bone specimens. After 60 days of treatment,
PGE 2 produced diffusely labeled trabecular bone area, in-
creased trabecular bone area, eroded and labeled trabecular
perimeter, mineral apposition rate, and bone formation rate
at all dose levels when compared with age-matched controls.
In rats given PGE 2 for longer time periods (120 and 180
days), trabecular bone area, diffusely labeled trabecular
bone area, labeled perimeter, mineral apposition, and bone
formation rates were sustained at the elevated levels
achieved earlier at 60-day treatment. The eroded perimeter
continued to increase until 120 days, then plateau. The ob-
servation that continuous systemic PGE 2 administration to
adult male rats elevated metaphyseal cancellous bone mass
to 3.5-fold of the control level within 60 days and maintained
it for another 120 days indicates that the powerful skeletal
anabolic effects of PGE 2 can be sustained with continuous
administration.
Key words: Prostaglandin E 2 - Long-term treatment - Can-
cellous bone - Bone formation - Bone resorption - Bone
turnover - Remodeling.
Previous studies in our laboratory demonstrated that sys-
temic administration of prostaglandin E 2 (PGE 2) to normal
rats produces large amounts of new bone mass in both can-
cellous and cortical bone regions, regardless of age and sex
[I-7]. A similar cortical bone increase induced by PGE 2 or
related compounds was also evidenced by studies done in
humans [8-10] and in dogs [I 1-15]. PGE 2 administration also
restored the cancellous bone mass in ovariectomy-induced
osteopenic metaphysis to above normal level [6-7]. PGE 2
stimulates osteoclastic resorption as well as osteoblastic re-
cruitment and activity. It activates bone modeling in the for-
mation mode and remodeling with bone formation exceeding
bone resorption to create a positive bone balance. These
studies indicate that PGE 2 is a powerful skeletal anabolic
agent when administered systemically and locally. However,
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it is not clear whether the skeletal anabolic effect of PGE 2
would be sustained with long-term administration as the
treatment periods of previous studies were short compared
with the skeletal remodeling period (sigma). Therefore, in
this study we have prolonged the treatment periods to 60,
120, and 180 days to investigate the long-term effects of
PGE 2 on metaphyseal cancellous bone in adult male rats.
The longest treatment period used in this study equals at
least four bone remodeling cycles for controls and five for
treated rats.
Materials and Methods
Seventy-four male 7-month-old Sprague-Dawley rats, weighing ap-
proximately 622 g (Charles River Laboratory, Inc., Portage, MI)
were acclimated to local vivarium conditions for 16 days. Five rats
were sacrificed at day 0 as beginning controls. The remaining rats
were divided into four groups for daily administration of 0, I, 3, and
6 mg/kg/day of PGE 2. Five to 7 rats from each group were serial
sacrificed at days 60, 120, and 180. During the experimental period,
the rats were allowed free access to water and pelleted commercial
natural product diet (Rodent Laboratory Chow 5001, Ralston-Purina
Co., St. Louis, MO).
All rats, except those killed at day 0, received injections of 1
ml/kg PGEz solution. Powdered PGE z (Upjohn, Kalamazoo, MI)
was first dissolved in 100% ethanol and further diluted with deion-
ized water into desired PGE2 concentrations (final ethanol concen-
tration was 20%) for 0, 1, 3, or 6 mg/kg/day groups. The daily in-
jections were given subcutaneously on the back. The rats were
weighed weekly and the volume of the injection solution was ad-
justed accordingly. All rats received subcutaneous injection of 25
mg/kg of tetracycline (achromycin-tetracycline hydrochloride; Led-
erie Laboratory, Pearl River, NY) 12 days before sacrifice, and 10
mg/kg of calcein (Sigma Chemical Co., St. Louis, MO) 2 days before
sacrifice. All animals were sacrificed by cardiac puncture under
ketamine anesthesia. The lungs, liver, adrenal glands, thymus,
spleen, and kidneys were removed and weighed.
The left tibia was removed and stored in 70% ethanol prior to
measuring of bone mineral density. Using single photon absorpti-
ometry (Norland Corporation, Fort Atkinson, WI), the proximal
tibia was scanned transversely at the mid-point between the distal
end of the soleal line and the proximal end of the tibiae. During the
measurement, bone mineral content and bone width were obtained
and bone mineral density was calculated [16].
The right tibia was removed, dissected, and cut into three equal
parts. The proximal third was fixed in formalin, dehydrated in eth-
anol, and defatted in acetone, then embedded in methyl methacry-
late (Eastman Organic Chemicals, Rochester, NY). Frontal sections
were cut and ground to 100 _m and microradiographed. Thereafter,
sections were mounted on plastic slides and further ground to a
thickness of 20 p,m and stained with 0.1% toluidine blue 0 (Fisher
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Fig. 1. Morphologic evidence of
remodeled trabecular packets in
rat proximal tibial metaphyseal
cancellous bone under (a) light
and (b) fluorescent microscopy.
(a) The 20 _m undecalcified
section shows two trabecular
packets with reversal lines
(black arrows) located on both
upper and lower surfaces
separated by interstitial lamellae
(white arrow). (b) The
appearance of tetracycline (TC)
and calcein (CL) labels in both
trabecular packets indicates that
they are newly formed trabecular
bone remodeling units. × 250.
Table !. Histomorphometric measurements and calculations
Measured parameters Abbreviations Definitions Unit
Total tissue area T.Ar
Total trabecular area TTb.Ar
Total trabecular perimeter TTb.Pm
Diffuse labeled new bone area DLNB.Ar
Lamellar trabecular bone area LTb.Ar
Lamellar trabecular bone perimeter LTb.Pm
Single label perimeter sL.Pm
Double label perimeter dL.Pm
lnterlabel width lr.L.Wi
lnterlabel width (growth) Ir.L.Wi.-G
Eroded perimeter E.Pm
Osteoid perimeter O.Pm
Wall width W.Wi
Calculated parameters Abbreviations
A area of (2.4 × 1.8 mm) in central metaphysis mm 2
Total cancellous bone area within total area mm 2
The perimeter of TTb.Ar mm
Cancellous bone area diffusely labeled
with tetracycline and/or calcein mm 2
Cancellous bone area with lamellar bone structure mm 2
The perimeter of LTb.Ar mm
The length of trabecular surface labeled with
tetracycline or calcein mm
The length of trabecular surface labeled with both
tetracycline and calcein mm
The distance between tetracycline and calcein labels ixm
The distance between tetracycline and calcein labels
in growth plate metaphyseal junction region _tm
The length of trabecular surface with Howship's lacuna _m
The length of trabecular surface covered with osteoid mm
The distance between reversal line and trabecular surface I_m
UnitFormulae
Percent total trabecular area -%TTb.Ar
Percent diffuse labeled new bone area %DLNB.Ar
Trabecular width Tb.Wi
Trabecular number Tb.N
Trabecular separation Tb.Sp
Percent eroded perimeter %E.Pm
Percent osteoid perimeter %O.Pm
Percent labeled perimeter %L.Pm
Mineral apposition rate MAR
Bone formation rates (bone area based) BFR
Formation period F. P
Resorption period R.P
Remodeling period Rm. P
Longitudinal growth rate LGR
TTb.Ar/T.Ar × 100 %
DLNB.Ar/T.Ar x 100 %
(2000/1.199) *TTb. A r/TTb. Pm l_m
I. 199/2*TTb.Pm/T.Ar #/mm
(2000* I. 199)*(T.Ar TTb.Ar)/TTb.Pm _m
E.Pm/LTb.Pm x 100 %
O.Pm/LTb.Pm x 100 %
(dL.Pm + sL.Pm/2)/LTb.Pm*I00 %
lr. L. Wi/lnterval _.m/day
(dL.Pm + sL.Pm/2)*MAR/LTb.Ar*365*lO0 %/year
W.Wi/MAR days
F.P x E.Pm/O.Pm days
F.P + R.P days
lr. L. Wi-G/Interval p.m/day
Scientific Co., Fair Lawn, N J), then coverslipped [6, 171. Trabecu-
lar packets were readily observed in these ground sections (Fig. I).
Microradiographs and 20 p,m thick undecalcified sections were
viewed qualitatively and/or quantitatively. Static and kinetic mea-
surements were performed on 20 _m thick undecalcified sections
using a digitizing image analyzing system, which consists of a light
or epifluorescent microscope, an Apple Macintosh Computer with a
digitizing pad, and a morphometry program named "Stereology"
(KSS Computer Engineers, Magna, UT). Except for longitudinal
bone growth, all measurements were performed using 156 × or 312
x magnifications on a 4.32 mm 2 (2.4 × 1.8 mm) area of central
metaphysis located 0.6 mm distal from the growth cartilage meta-
physeal junction. The 0.6 mm metaphyseal region was omitted in
order to focus on cancellous bone changes in the secondary spon-
giosa. All static and dynamic histomorphometric measurements and
calculations are summarized in Table 1 according to Jee et al. [17]
and Parfitt et al. [18]. We have included an additional measurement,
the amount of diffusely labeled trabecular bone (Fig. 2), represent-
ing woven bone formed at 12 and 2 days before sacrifice when
fluorescent markers were injected. This parameter underestimated
the total amount of woven bone.
Statistical differences between age-matched control and treat-
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Fig. 2. Fluorescent micrographs
of trabeculae from proximal
tibial metaphyses of adult male
rats as (a) age-matched control
and (b) treated with 6 mg
PGEJkg/day for 60 days.
PGE2-treated rat exhibits greater
interlabeling distance of double
labels (dL) than control rat la
versus b). Also diffusely labeled
woven trabecula (*) is observed
in treated rat only (b). x 250.
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Fig. 3. Time course of the body weight changes in control and
PGE2-treated rats during the experimental period.
ment groups were evaluated for each time period using the Kruskal-
Wallis test [19].
Results
In all PGE2-treated rats, diarrhea was observed 1 hour after
injection. Their body weight decreased about 17% during the
first 60 days and remained depressed thereafter whereas the
body weight of control rats increased continuously through-
out the experiment (Fig. 3). In the treatment rats, soft tissue
weights showed significant increases in adrenal glands, liver,
kidneys, and lungs when normalized to body weight (Fig. 4).
No significant change was observed in weights of thymus
and spleen (data not shown).
Significant increases in proximal tibial bone mineral den-
sity were detected in rats treated with 3 and 6 mg PGE2/
kg/day compared with age-matched controls (Fig. 5). Bone
mineral density increased by 22 and 17% at 120 and 180 days
for 3 mg/kg/day dose level and by 18, 17, and 17% at 60, 120,
and 180 days for 6 mg/kg/day dose level.
The longitudinal growth rate was depressed in a dose-
dependent manner; the magnitude of this depression in-
creased with longer treatment period (Fig. 6). Growth plates
were partially fused in most rats treated with PGE2 for 180
days at higher dose groups; a few small pieces of cartilage
tissue were scattered along the fused plate.
The obvious cancellous bone changes are apparent in
Figure 7. During the treatment period, bone mass declined
with aging in control animals (c versus a). But bone mass
increased in a dose-dependent manner in animals treated
with 1,3, and 6 mg PGE2/kg/day for 60 days (d, g, and j). The
elevated bone mass was maintained at the same level for
each dose group by daily administration for another 60 days
(e, h, and k) and 120 days (f, i, and 1).
Figure 8 summarizes static morphometric changes for
control and PGEz-treated animals. PGE2 administration pro-
duced diffusely labeled, new woven trabecular bone at all
dose levels throughout the experiment. Significant dose-
dependent increases were observed in total trabecular bone
area, trabecular width, trabecular number, and wall width.
Similarly, decreases in trabecular separation after 60-day
treatment when compared with age-matched controls were
also observed. For 120- and 180-day treatments, these pa-
rameters were maintained and the remodeling of woven to
lamellar bone was underway at the 60-day treatment levels,
except that trabecular width continued to increase until 120
days and then plateau at 6 mg dose levels. Dynamic histo-
morphometric changes are listed in Figure 9. PGE 2 admin-
istration for 60 days increased percent eroded perimeter,
osteoid perimeter, percent labeled perimeter, mineral appo-
sition rate, and bone formation rate in a dose-dependent
manner; but it decreased the resorption, formation, and re-
modeling periods. The eroded perimeter continued to in-
crease until 120 days and plateau thereafter, whereas all
other parameters were maintained at 60-day treatment levels
after 120 and 180 days of daily PGE2 treatment.
Discussion
The current study demonstrated that the powerful skeletal
anabolic effects of PGE 2 can be sustained with daily admin-
istration of PGE2 for 180 days. This equals at least four and
five bone remodeling cycles for control and treated rats,
respectively. The average time for completing one remodel-
ing cycle was 45 days in control and 35 days in treated ani-
mals (Fig. 9h). The skeletal dynamics in the current and
previous studies [2, 6, 7] suggest that in vivo PGE 2 admin-
istration in all rats (regardless of whether they are male or
female, young or aged, estrogen-deplete osteopenic or nor-
mal) acts in the same manner to increase metaphyseal can-
cellous bone mass. It stimulates bone modeling by producing
new woven trabeculae. It also stimulates bone remodeling
by increasing both bone formation and bone resorption on
the existing bone surface but it favors bone formation. Thus,
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Fig. 4. Time course of the soft tissue weight changes in control and PGEz-treated rats during the experimental period.
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Fig. 5. Time course of proximal tibial bone mineral density changes
in control and PGE 2 rats during the experimental period.
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the bone balance is shifted to the positive direction. Further-
more, PGE 2 shortens the entire bone remodeling period.
During the first 60-day treatment, PGE 2 induced an in-
crease in bone formation involving new woven bone produc-
tion, labeled trabecular perimeter, mineral apposition rate,
and therefore, bone formation rate. All these formative pa-
rameters reached peak values sometime before 60 days.
However, PGE 2 also induced a minor increase in bone re-
sorption. Despite this minor increase, the imbalance be-
tween bone resorption and bone formation grew, because a
smaller ratio of eroded to labeled trabecular perimeter was
seen in treated rats than in controls (0.21 versus 0.28). These
changes led to a positive bone balance so that cancellous
bone mass accumulated to the maximal level within the first
60 days. Subsequently, formative parameters were sustained
at the elevated levels whereas eroded trabecular perimeter
increased progressively until 120 days to a level that offset
the new bone formation as the ratio of eroded to labeled
perimeter returned to near the control level (0.26). Woven
bone formations decreased at all dose levels, but the total
trabecular bone mass remained approximately constant, in-
dicating that woven bone was being replaced by lamellar
bone. These changes guaranteed the maintenance of the el-
evated bone mass. Thus, a new equilibrium (steady state)
was achieved with an elevated bone mass and an elevated,
zero-balanced bone turnover in rats treated with PGE 2 for
120 and 180 days.
PGE2-treated male rats exhibited a reduced rate of Ion-
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Fig. 7. Microradiographs showing cancellous bone changes in prox-
imal tibial metaphyses from age-matched controls at day 60 (a), 120
(b) and 180 (e); from rats treated daily with PGEz at 1 mg/kg/day
dose level for 60 (d), 120 (e), and 180 (f) days; at 3 mg/kg/day dose
level for 60 (g), 120 (h), and 180 (i) days; at 6 mg/kg/day dose level
for 60 (j), 120 (k), and 180 (I) days.
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Fig. 8. Time course of cancellous bone static morphometric changes in proximal tibial metaphyses of control and PGE2-treated rats.
gitudinal bone growth in proximal tibiae. Similar results have
been reported by others [20] on PGE2-treated, rapidly grow-
ing male rats in our earlier studies [2--4] and on PGEt-treated
young male rats. Interestingly, longitudinal bone growth rate
is increased in a dose-dependent manner in PGE2-treated
normal female rats [6--7]. The mechanism of this sex-
dependent bone elongation effect is very intricate as it is not
estrogen dependent. Enhanced bone elongation was also
seen in estrogen-depleted, ovariectomized rats [6--7]. Thus,
leaving the possibility that it may be androgen dependent,
the stimulatory effect on bone elongation of PGE 2 may be
blocked in an androgen-rich environment. Unfortunately,
very little is known about the effects of androgen on the
skeleton [21], especially on bone elongation. However, the
hypothesis could be tested by treating gonadectomized male
rats with PGE 2.
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